Streetbeat News

Stock Prices

MRVL

Deep-pocketed investors have shown a bullish sentiment towards Marvell Tech (NASDAQ:MRVL), with options activity indicating a focus on a price band between $57.5 and $87.5. The options market's interest, with 69% bullish and 30% bearish sentiment, suggests significant expectations for MRVL's stock movement. Analysts have set a consensus target price of $92.0 for MRVL, with ratings ranging from Overweight to Buy. The stock is currently up 3.93% at $68.72, with potential overbought signals from RSI indicators.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:31 pm

HIG

Over the past 15 years, Hartford Finl Servs Gr (NYSE:HIG) has produced an average annual return of 18.75%, outperforming the market by 5.54%. A $1000 investment in HIG 15 years ago would now be worth $12,862.42. This showcases the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:30 pm

AON

Over the past 10 years, Aon (NYSE:AON) has produced an average annual return of 14.5%, outperforming the market by 3.78% on an annualized basis. A $1000 investment in AON a decade ago would be worth $3,897.96 today, showcasing the impact of compounded returns on cash growth. Aon's current market capitalization stands at $64.96 billion.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:30 pm

MGM

MGM Resorts International's stock is trading higher following a Buy rating initiation and a $61 price target from Mizuho.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:29 pm

VKTX

Viking Therapeutics Inc (NASDAQ:VKTX) released results from a Phase 1 trial of VK2735, an oral obesity drug, showing dose-dependent weight reductions and minimal side effects. The company plans to continue dose escalation and initiate a Phase 2 trial in the second half of 2024. VKTX shares surged 20.90% to $83.64.

Portfolio Pulse from Vandana Singh

March 26, 2024 | 2:25 pm

STX

WDC

Western Digital's stock is trading higher, potentially due to Seagate's stock rise following an upgrade from Morgan Stanley. This suggests a sympathetic movement in the sector influenced by analyst ratings.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:22 pm

TMC

TMC Metals shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:20 pm

SYRE

Stifel analyst Alex Thompson has reiterated a Buy rating on Spyre Therapeutics (NASDAQ:SYRE) and increased the price target from $36 to $54, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 2:18 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for March 26th, 2024, provides trading strategies for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA based on proprietary formulas. It outlines potential price levels for bullish and bearish scenarios for each asset and highlights the importance of monitoring key economic data releases throughout the day that could impact market dynamics.

Portfolio Pulse from RIPS

March 26, 2024 | 2:15 pm

CVS

CVS Health's (NYSE:CVS) short percent of float has decreased by 16.38% since the last report, with 30.76 million shares sold short, representing 2.45% of available shares. This decrease in short interest could indicate a more bullish sentiment towards CVS Health compared to its peers, where the average short interest as a percentage of float is 10.12%.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 2:15 pm